Correlation Between X4 Pharmaceuticals and Enveric Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Enveric Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Enveric Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Enveric Biosciences, you can compare the effects of market volatilities on X4 Pharmaceuticals and Enveric Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Enveric Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Enveric Biosciences.

Diversification Opportunities for X4 Pharmaceuticals and Enveric Biosciences

0.04
  Correlation Coefficient

Significant diversification

The 3 months correlation between XFOR and Enveric is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Enveric Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enveric Biosciences and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Enveric Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enveric Biosciences has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Enveric Biosciences go up and down completely randomly.

Pair Corralation between X4 Pharmaceuticals and Enveric Biosciences

Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 1.17 times more return on investment than Enveric Biosciences. However, X4 Pharmaceuticals is 1.17 times more volatile than Enveric Biosciences. It trades about 0.04 of its potential returns per unit of risk. Enveric Biosciences is currently generating about -0.35 per unit of risk. If you would invest  74.00  in X4 Pharmaceuticals on November 4, 2024 and sell it today you would lose (4.00) from holding X4 Pharmaceuticals or give up 5.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

X4 Pharmaceuticals  vs.  Enveric Biosciences

 Performance 
       Timeline  
X4 Pharmaceuticals 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in X4 Pharmaceuticals are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, X4 Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.
Enveric Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enveric Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

X4 Pharmaceuticals and Enveric Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with X4 Pharmaceuticals and Enveric Biosciences

The main advantage of trading using opposite X4 Pharmaceuticals and Enveric Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Enveric Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enveric Biosciences will offset losses from the drop in Enveric Biosciences' long position.
The idea behind X4 Pharmaceuticals and Enveric Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets